Shi Tianming: Clinical Trials

1 trial sponsored by Shi Tianming, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Shi Tianming: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Rimegepant for Acute Dizziness
Rimegepant 75mg Orally Disintegrating Tablets (ODT), Betahistine Mesylate tablet - Dizziness
Phase 2 / Phase 3Not yet recruitingShi Tianming3702026-03-202026-02-27

Conditions studied

Dizziness (1)

Interventions

Betahistine (1)  ·  rimegepant sulfate (1)